This panel examines your risk for developing neurodegenerative disease, including Alzheimer’s, dementia, and Parkinson’s. This test may provide important information that shapes the planning and decision-making process for treatment, including psychosocial counseling, research study enrollment, therapeutic treatments, and support programs. Additionally, an individual with a known diagnosis of Alzheimer’s, dementia, or Parkinson’s may want to be tested in order to determine if the cause of disease is genetic and may impact family members.
What Can This Test Tell Me?
This test may determine your risk of developing a neurodegenerative disorder. It may also show genes that play a role in early-onset Alzheimer’s. This test should be ordered by a physician and interpreted with a genetic counselor, so that all patient and provider questions may be answered.
How to Get Tested:
Step 1: Your physician orders a test based on medical necessity, and your cheek swab is collected.
Step 2: Our billing team verifies coverage and begins testing if approved. If coverage is denied, we contact you to discuss options.
Step 3: Within 2-3 weeks, testing is completed, reviewed by our clinical team, and a report is electronically sent back to your doctor.
Step 4: Your doctor reviews the report with you, and you may discuss results with a genetic counselor!
Cost and Coverage:
Billing through insurance: a doctor's order with medical necessity for testing is required to bill insurance. Our in-house billing team is happy to answer your questions!
LVG does not accept direct payment for this test.
Who Should Have ADP Testing :
Individuals with a personal history of Alzheimer’s, dementia, or Parkinson’s disease are the best candidates for testing.
APOE, APP, ATP13A2, ATP1A3, C9orf72, CSF1R, DCTN1, DNMT1, EIF4G1, FBXO7, GBA, GCH1, GRN, HTRA2, LRRK2, MAPT, NOTCH3, PARK7, PINK1, PLA2G6, POLG, PRKN, PRKRA, PRNP, PSEN1, PSEN2, SLC6A3, SNCA, SNCB, TAF1, TH, TREM2, TYROBP, UCHL1, and VPS35
Custom panels are available! Contact us to learn more.